Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
109.87
+4.17 (3.95%)
At close: Jul 24, 2026, 4:00 PM EDT
108.70
-1.17 (-1.06%)
After-hours: Jul 24, 2026, 7:53 PM EDT
Monopar Therapeutics Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Monopar Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $113.62. The average 1-year stock price forecast is 3.41% higher than the current stock price, while the lowest is $100 (-8.98%) and the highest is $130 (+18.32%).
Price Target: $113.62 (+3.41%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Monopar Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 9 | 9 | 9 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Maintains $117 | Buy | Maintains | $117 | +6.49% | Jul 24, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $115 | Buy | Maintains | $115 | +4.67% | Jul 23, 2026 |
| Barclays | Barclays | Buy Maintains $125 | Buy | Maintains | $125 | +13.77% | Jul 23, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $105 → $125 | Buy | Reiterates | $105 → $125 | +13.77% | Jul 22, 2026 |
| Lake Street | Lake Street | Buy Maintains $103 | Buy | Maintains | $103 | -6.25% | Jun 30, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
15.84M
EPS This Year
-2.90
from -1.85
EPS Next Year
-3.14
from -2.90
EPS and Forward PE are based on non-GAAP adjusted numbers.